Biotechnology · Healthcare
Board Member
2023-05-01–present
Board Member
Keros Therapeutics, Inc. (KROS)Equibles does not estimate personal net worth.
Get an email with a short summary when Keros Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get KROS alertsAlpna Seth is recorded as Board Member at Keros Therapeutics, Inc. (KROS) since May 1, 2023. Keros Therapeutics, Inc. reported in an 8-K filed April 19, 2023 that Alpna Seth was appointed director of the Company, effective May 1, 2023. Keros Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Keros Therapeutics, Inc. includes Jasbir Seehra (CEO, Chairman and Board Member), Jean-Jacques Bienaimé (Chairman and Board Member), Annita Tanini (Chief Accounting Officer) and 3 others.
“On April 13, 2023, the board of directors (the "Board") of Keros Therapeutics, Inc. (the "Company"), based upon a recommendation from the Nominating and Corporate Governance Committee of the Board, voted to increase the size of the Board to eight members and appoint Dr. Alpna Seth as a director of the Company, effective on May 1, 2023.”
2023-05-01–present
Biotechnology · Healthcare
Board Member
2023-05-01–present